These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30309255)
1. Platelet Activation and Platelet-Leukocyte Aggregates in Type I Diabetes Mellitus. Zahran AM; El-Badawy O; Mohamad IL; Tamer DM; Abdel-Aziz SM; Elsayh KI Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):230S-239S. PubMed ID: 30309255 [TBL] [Abstract][Full Text] [Related]
2. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects. Vaidyula VR; Boden G; Rao AK Platelets; 2006 Dec; 17(8):577-85. PubMed ID: 17127486 [TBL] [Abstract][Full Text] [Related]
3. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection. Nkambule BB; Davison G; Ipp H Platelets; 2015; 26(3):250-7. PubMed ID: 24831969 [TBL] [Abstract][Full Text] [Related]
4. Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals. Nkambule BB; Davison G; Ipp H J Thromb Thrombolysis; 2015 Nov; 40(4):458-67. PubMed ID: 25899563 [TBL] [Abstract][Full Text] [Related]
5. The basis examination of leukocyte-platelet aggregates with CD45 gating as a novel platelet activation marker. Nagasawa A; Matsuno K; Tamura S; Hayasaka K; Shimizu C; Moriyama T Int J Lab Hematol; 2013 Oct; 35(5):534-41. PubMed ID: 23356866 [TBL] [Abstract][Full Text] [Related]
6. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus. Nomura S; Kanazawa S; Fukuhara S J Diabetes Complications; 2003; 17(3):153-9. PubMed ID: 12738400 [TBL] [Abstract][Full Text] [Related]
7. Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetes. Neubauer H; Setiadi P; Günesdogan B; Pinto A; Börgel J; Mügge A Diabet Med; 2010 Apr; 27(4):384-90. PubMed ID: 20536508 [TBL] [Abstract][Full Text] [Related]
8. Expression of EMMPRIN (CD147) on circulating platelets in vivo. Pennings GJ; Yong AS; Kritharides L J Thromb Haemost; 2010 Mar; 8(3):472-81. PubMed ID: 19995409 [TBL] [Abstract][Full Text] [Related]
9. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease. Jakubowski JA; Zhou C; Winters KJ; Lachno DR; Howard J; Payne CD; Mant T; Jurcevic S; Frelinger AL Platelets; 2015; 26(5):474-9. PubMed ID: 25140584 [TBL] [Abstract][Full Text] [Related]
10. The phenotype of cryopreserved platelets influences the formation of platelet-leukocyte aggregates in an Winskel-Wood B; Padula MP; Marks DC; Johnson L Platelets; 2023 Dec; 34(1):2206916. PubMed ID: 37143347 [TBL] [Abstract][Full Text] [Related]
11. Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates. Klinkhardt U; Kuczka K; Harder S Thromb Res; 2003; 111(4-5):251-7. PubMed ID: 14693172 [TBL] [Abstract][Full Text] [Related]
13. Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia? Sener A; Ozsavci D; Oba R; Demirel GY; Uras F; Yardimci KT Clin Biochem; 2005 Dec; 38(12):1081-7. PubMed ID: 16253220 [TBL] [Abstract][Full Text] [Related]
14. Platelet function alterations and their relation to P-selectin (CD62P) expression in children with iron deficiency anemia. Yıldırım ZK; Orhan MF; Büyükavcı M Blood Coagul Fibrinolysis; 2011 Mar; 22(2):98-101. PubMed ID: 21245745 [TBL] [Abstract][Full Text] [Related]
15. Platelet activation and platelet-leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis. Keawvichit R; Khowawisetsut L; Chaichompoo P; Polsrila K; Sukklad S; Sukapirom K; Khuhapinant A; Fucharoen S; Pattanapanyasat K Ann Hematol; 2012 Nov; 91(11):1685-94. PubMed ID: 22847151 [TBL] [Abstract][Full Text] [Related]
16. Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy. Hu H; Li N; Yngen M; Ostenson CG; Wallén NH; Hjemdahl P J Thromb Haemost; 2004 Jan; 2(1):58-64. PubMed ID: 14717967 [TBL] [Abstract][Full Text] [Related]
17. Platelet and monocyte activation in acute ischemic stroke--is there a correlation with stroke etiology? Oberheiden T; Nguyen XD; Fatar M; Elmas E; Blahak C; Morper N; Dempfle CE; Hennerici M; Borggrefe M; Kälsch T Clin Appl Thromb Hemost; 2012; 18(1):87-91. PubMed ID: 21733938 [TBL] [Abstract][Full Text] [Related]
18. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485 [TBL] [Abstract][Full Text] [Related]
19. Short- and long-term effects of hemodialysis on platelet and monocyte activity markers of atherosclerosis in patients with end-stage renal disease. Benck U; Stach K; Jung S; Krämer BK; Kälsch T; Kälsch AI Cardiol J; 2018; 25(5):595-600. PubMed ID: 29240958 [TBL] [Abstract][Full Text] [Related]
20. The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke. Pawelczyk M; Baj Z; Chmielewski H; Kaczorowska B; Klimek A Cerebrovasc Dis; 2009; 27(2):131-7. PubMed ID: 19047793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]